Search results for: 'top test'

The healthcare cloud market is undergoing rapid transformation, driven by strategic imperatives that will redefine industry dynamics in 2026. Frost & Sullivan’s analysis identifies 10 critical shifts shaping this evolution, anchored in technological innovation, regulatory compliance, and operational resilience. Cloud adoption is no longer limited t...

03 Jul 2019  |  Global  |  Market Research

Global Employee Health Management IT Market, Forecast to 2024

Well-Being and Corporate Performance are Top Priorities

Infographics

×

Key Issues Addressed

The purpose of this research service is to present a comprehensive analysis of the global employee health management information technology (EHM IT) market, with respect to how digital health platforms are expected to help employers devise and scale clinical and wellness programs that ensure employee well-being and improve organizational productivi...

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (earlie...

The global smart hospital market is entering a pivotal growth phase, moving beyond pilot deployments into enterprise-wide transformation. Smart hospitals represent a digitally enabled model of care delivery, built on the integration of IoT, interoperability, AI, digital twins, and extended care models such as hospital-at-home and virtual care. In t...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

The report describes how predictive biomarkers are changing the global landscape of neuroregeneration and transitioning from the concept of control of brain injury to an active repair of the brain. This report describes how brain injuries from scans were being replaced by blood tests being developed to measure the burden of Alzheimer's disease, mea...

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, intelligent laboratory ecosystems enabled by robotics,...